skip to Global Navigation Bar skip to main content

homeHome > About Us > Press Release > News


News Content
Daewoong Pharmaceutical Sets Standard for Global Drug Safety Reporting with Oracle
Date 2019-01-17 Hit 2158
News List
Prev Daewoong’s ‘NABOTA’ submitted the form to change clinical test plans in China.
Next The clinical findings of Botulinum Toxin manufactured by Daewoong have been published on international journal regarding the comparison with Botox